tiprankstipranks
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
US Market
TERN
Terns Pharmaceuticals
RESEARCH TOOLSreports

Terns Pharmaceuticals (TERN) Income Statement

545 Followers

Terns Pharmaceuticals Income Statement

Last quarter (Q4 2025), Terns Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Terns Pharmaceuticals's net income was $-23.57M. See Terns Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Operating Expenses
$ 110.12M$ 101.87M$ 102.56M$ 62.03M$ 50.86M
Depreciation and Amortization
$ 0.00$ 896.00K$ 881.00K$ 1.03M$ 512.00K
EBITDA
$ -110.12M$ -100.97M$ -101.68M$ -61.00M$ -49.35M
Operating Income
$ -110.12M$ -101.87M$ -102.56M$ -62.03M$ -49.86M
Other Income/Expenses
$ 14.50M$ 13.28M$ 12.59M$ 2.04M$ 210.00K
Pretax Income
$ -95.63M$ -88.59M$ -89.97M$ -59.99M$ -49.65M
Net Income
$ -96.21M$ -88.85M$ -90.21M$ -60.34M$ -50.16M
Per Share Metrics
Basic EPS
$ -1.03$ -1.12$ -1.27$ -1.67$ -1.98
Diluted EPS
$ -1.03$ -1.12$ -1.27$ -1.67$ -1.98
Weighted Average Shares Outstanding
 93.17M 79.51M 71.26M 36.03M 25.27M
Weighted Average Shares Outstanding (Diluted)
 93.17M 79.51M 71.26M 36.03M 25.27M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History